A nurse caring for a client with myasthenia gravis knows that the medical and nursing care for this client includes all the following interventions. Which is a primary treatment to improve neuromuscular transmission?

A nurse caring for a client with myasthenia gravis knows that the medical and nursing care for this client includes all the following interventions. Which is a primary treatment to improve neuromuscular transmission?

• A. Anticholinesterase drugs (prostigmin, mestinon, tensilon)
• B. Mechanical ventilation (observe for aspiration, suction as needed)
• C. Airway techniques for swallowing: chin tuck, double swallow
• D. Feed patient on high-Fowler's position

Answer: (A)

The essential idea here is that improving transmission at the neuromuscular junction addresses the heart of myasthenia gravis. In MG, antibodies block nicotinic acetylcholine receptors, so fewer receptors are available and signaling across the junction is weakened, causing fatigable weakness. Anticholinesterase drugs inhibit acetylcholinesterase, the enzyme that breaks down acetylcholine. By blocking this enzyme, acetylcholine remains longer in the synaptic cleft and in higher concentration, increasing its chances to bind the remaining receptors. This directly boosts neuromuscular transmission and improves muscle strength, which is why these drugs are considered the primary treatment for MG. The other interventions provide important support but don’t fix the underlying transmission problem: mechanical ventilation and airway management help during respiratory compromise, while swallowing and positioning strategies aid safety and comfort but don’t enhance NMJ signaling.

The essential idea here is that improving transmission at the neuromuscular junction addresses the heart of myasthenia gravis. In MG, antibodies block nicotinic acetylcholine receptors, so fewer receptors are available and signaling across the junction is weakened, causing fatigable weakness. Anticholinesterase drugs inhibit acetylcholinesterase, the enzyme that breaks down acetylcholine. By blocking this enzyme, acetylcholine remains longer in the synaptic cleft and in higher concentration, increasing its chances to bind the remaining receptors. This directly boosts neuromuscular transmission and improves muscle strength, which is why these drugs are considered the primary treatment for MG.

The other interventions provide important support but don’t fix the underlying transmission problem: mechanical ventilation and airway management help during respiratory compromise, while swallowing and positioning strategies aid safety and comfort but don’t enhance NMJ signaling.